Keyphrases
Tuberculosis
100%
Antitubercular
100%
Host Environment
100%
Pyrazinamide
100%
Pharmacokinetics
50%
Pharmacokinetic Study
50%
Metabolic Response
50%
Immune Response
50%
Molecular Targets
50%
Host Immune Response
50%
Antagonism
50%
Mechanism of Action
50%
First-line Therapy
50%
Host Factors
50%
Small Animal Model
50%
Non-replicating
50%
Relapse Rate
50%
Treatment Limitation
50%
Small Patients
50%
Bacillus
50%
Drug Regimen
50%
Model Samples
50%
Host Metabolism
50%
First-line Anti-tuberculosis Drugs
50%
Pharmacopoeia
50%
TB Drugs
50%
Patient Samples
50%
Future Therapies
50%
Pharmacology, Toxicology and Pharmaceutical Science
Pyrazinamide
100%
Pharmacokinetics
100%
Molecular Target
50%
Target Activity
50%
Recurrence Risk
50%
Host Factor
50%
Medicine and Dentistry
Pharmacokinetics
100%
Pyrazinamide
100%
Immune Response
50%
Host Factor
50%
Recurrence Risk
50%